The difficulty defining “benefit” of new antineoplastic strategies Maurie Markman Editorial Pages: 569 - 570
Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin Zahid H. SiddikGerald ThaiAbdul R. Khokhar Original Papers Pages: 571 - 577
Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts Borbála VinczeIstván PályiImre Mezö Original Papers Pages: 578 - 584
Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs Paola PeregoAmerigo BoiardiFranco Zunino Original Papers Pages: 585 - 592
Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing Beverly A. TeicherEnrique Alvarez SotomayorKrishna Menon Original Papers Pages: 593 - 598
Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cells J. NordenbergJ. KornfeldY. Sidi Original Papers Pages: 599 - 604
Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells Gigliola SicaFortunata IacopinoLuca Marini Original Papers Pages: 605 - 609
Hypercalcemia in patients with breast cancer: a survival study S. de WitF. J. Cleton Original Papers Pages: 610 - 614
The Third International Symposium of the Hiroshima Cancer Seminar: Tumor-suppressor genes Eiichi TaharaWataru Yasui Meeting Report Pages: 615 - 619
Third Colloquium on Cellular Signal Transduction: cell-cylce signalling F. MarksD. Werner Meeting Report Pages: 620 - 624
Symposium on Quality Assurance and Good Clinical Practice (GCP) in Cancer Drug Development A. L. KranichG. GastlG. A. Nagel Meeting Report Pages: 625 - 627